Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients
Annals of Thoracic Surgery, 09/23/09
Berry MF et al. – Patients older than 70 years of age can undergo lobectomy for lung cancer with low morbidity and mortality. Advanced age and the use of a thoracotomy increased the risk of complications in this patient population.
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09
Today in Surgery/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Embolism and Deep Venous Thrombosis in Trauma
Archives of Surgery, 10/20/09
Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer
Annals of Surgical Oncology, 11/18/09
Anterior Minithoracotomy: A Direct Approach to the Difficult Hilum for Upper Lobectomy, Pneumonectomy, and Sleeve Lobectomy
Annals of Surgical Oncology, 11/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


